Erythrocyte metabolism and antioxidant status of patients with wilson disease with hemolytic anemia

Pediatric Research

Volumn 59, Issue 4 PART 1, 2006, Pages 593-597

  Attri, Savita ^a   Sharma, Neeraj ^a   Jahagirdar, Sujeet ^a   Thapa, Babu Ram ^a   Prasad, Rajendra ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CERULOPLASMIN; COPPER; FREE RADICAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEXOKINASE; LIPID; PENICILLAMINE; SUPEROXIDE DISMUTASE; TRANSITION ELEMENT; URIC ACID;

ADOLESCENT; ARTICLE; ATP7B GENE; AUTOSOMAL RECESSIVE DISORDER; CATALYSIS; CATALYST; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME INHIBITION; ERYTHROCYTE METABOLISM; FEMALE; FOLLOW UP; GENE; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; LIVER INJURY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHOOL CHILD; URIC ACID BLOOD LEVEL; WILSON DISEASE;

ADOLESCENT; ANEMIA, HEMOLYTIC; ANTIOXIDANTS; CERULOPLASMIN; CHILD; COPPER; ERYTHROCYTES; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; PLASMA;

EID: 33646708274     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000203098.77573.39     Document Type: Article

References (39)

1. Scheinberg IH, Sternlieb I 1984 Wilson's Disease. WB Saunders, Philadelphia, pp 25-37.
2. Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, Brzustowicz LM, Cayanis E, Vitale E, Russo JJ 1993 Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 5:338-343
3. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G 1991 Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 115:720-726
4. Deiss A, Lee GR, Cartwright GE 1970 Hemolytic anemia in Wilson's disease. Ann Intern Med 73:413-418
5. Forman SJ, Kumar KS, Redeker AG, Hochstein P 1980 Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms. Am J Hematol 9:269-275
6. Boulard M, Blume KG, Beutler E 1972 The effect of copper on red cell enzyme activities. J Clin Invest 51:459-461
7. Feig SA, Segel GB, Shohet SB, Nathan DG 1972 Energy metabolism in human erythrocytes II. Effect of glucose depletion. J Clin Invest 51:1547-1554
8. Bavdekar AR 2004 Therapeutic and management challenges in Wilson's Disease. J Gastroenterol Hepatol 19:S391-S395
9. Tanaka R, Nakai K 1977 Hemolysis and morphological changes in rat erythrocytes with mercurials. Jpn J Pharmacol 27:413-419
10. Tashima Y 1975 Removal of protein interference in Fiske-Subbarow method by sodium dodecyl sulphate Anal Biochem 69:410-414
11. Beutler E 1984 Red Cell Metabolism: A Manual of Biochemical Methods. Grune and Stratton, Orlando, FL, pp 38-39.
12. Varley H, Gowenlock AH, Bell M 1980 Glucose-6-phosphate dehydrogenase. In: Varley H, Gowenlock A (eds) Varley's Practical Clinical Biochemistry. Whitefriar Press, Tonbridge, pp 729-731.
13. Beutler E, Duron O, Kelly BM 1963 Improved method for the determination of blood glutathione. J Lab Clin Med 61:882-888
14. Jain SK 1988 Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 937:205-210
15. Kono Y 1978 Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186-189
16. Luck H 1963 A spectrophotometric method for the estimation of catalase. In: Bergmeyer HV (ed) Methods of Enzymatic Analysis. Verlag Chemie, Weinheim, pp 886-888
17. Flohe L, Gunzler WA 1984 Assays of glutathione peroxidase. Methods Enzymol 105:114-121
18. Carlberg I, Mannervik B 1985 Glutathione reductase. In: Meister A (ed) Methods in Enzymology. Academic Press, New York, pp 484-490.
19. Roe JM, Kuether CA 1943 Detection of ascorbic acid in whole blood and urine through the 2,4-DNPH derivative of dehydroascorbic acid. J Biol Chem 147:399-407
20. Duncan PH, Gochman N, Cooper T, Smith E, Bayse D 1982 A candidate reference method for uric acid in serum. I. Optimization and evaluation. Clin Chem 28:284-290
21. Sedlak J, Lindsay RH 1968 Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192-205
22. Lee BL, Chua SC, Ong HY, Ong CN 1992 High-performance liquid chromatographic method for routine determinations of vitamins A and E and beta-carotene in plasma. J Chromatogr 581:41-47
23. Lindeman JH, van Zoeren-Grobben D, Schrijver J, Speek AJ, Poorthuis BJ, Berger HM 1989 The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatr Res 26:20-24
24. Ravin HA 1961 An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 58:161-168
25. Prasad R, Kaur G, Walia BN 1998 A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives. Biol Trace Elem Res 63:153-155
26. Rother RP, Bell L, Hillmen P, Gladwin MT 2005 The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653-1662
27. Hoshino T, Kumasaka K, Kawano K, Yamagishi F, Koyama I, Fujimori-Arai Y, Nakajima T, Komoda T 1995 Low serum alkaline phosphatase activity associated with severe Wilson's disease. Is the breakdown of alkaline phosphatase molecules caused by reactive oxygen species? Clin Chim Acta 238:91-100
28. Bowler K, Duncan CJ 1970 The effect of copper on membrane enzymes. Biochim Biophys Acta 196:116-119
29. Lai JC, Blass JP 1984 Neurotoxic effects of copper: inhibition of glycolysis and glycolytic enzymes. Neurochem Res 9:1699-1710
30. Palamanda JR, Kehrer JP 1993 Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione. Lipids 28:427-431
31. Halliwell B, Gutteridge JM 1984 Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1-14
32. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M 1995 Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 37:219-226
33. von Herbay A, de Groot, H, Hegi U, Stremmel W, Strohmeyer G, Sies H 1994 Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 20:41-46
34. Hochstein P, Kumar KS, Forman SJ 1980 Lipid peroxidation and the cytotoxicity of copper. Ann N Y Acad Sci 355:240-248
35. Blum J, Fridovich I 1985 Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 240:500-508
36. 2, is an affinity reagent for the inactivation of yeast Cu, Zn superoxide dismutase: modification of one histidine per subunit. Arch Biochem Biophys 224:579-586
37. Halliwell B, Gutteridge JM 1990 The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1-8
38. Spitsin S, Hooper DC, Leist T, Streletz LJ, Mikheeva T, Koprowskil H 2001 Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult Scler 7:313-319
39. Langley SC, Brown RK, Kelly FJ 1993 Reduced free-radical trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 33:247-250